Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of British Columbia

$956,250.00

Mitophagy as a target for antifungal therapy

EF 2023-24

Résumé
Humans are continuously exposed to fungi that can potentially cause disease or allergic reactions. For example, the pathogenic fungus Cryptococcus neoformans causes life threatening meningitis in people with defective immune systems. The global impact of this fungal pathogen is dramatically illustrated by the fact that it is responsible ~15% of deaths in patients with Acquired Immune Deficiency Syndrome (AIDS). C. neoformans is therefore a major threat to the ~37 million people suffering from AIDS worldwide. Alarmingly, a related species, Cryptococcus gattii, has emerged as a primary pathogen with the ability to cause meningitis in people with healthy immune systems. The disease caused by C. gattii is particularly relevant to the health of Canadians because the fungus has caused an outbreak in British Columbia. The long-term goal of our research project is to acquire knowledge that will lead to new strategies to prevent and/or effectively treat the infections caused by fungal pathogens. In particular, we are working to acquire a detailed understanding of the weapons that fungi deploy to attack people, and to use our new knowledge in strategies to treat fungal diseases. In our current project, we will determine how C. neoformans senses nutrients and stress conditions relevant to growth inside animal hosts. We plan to use the latest technologies in genetics, biochemistry and cell biology to complete our objectives. The new knowledge we obtain may lead to therapies that enhance the ability of our immune systems to control disease by preventing the fungus from growing during infection. These studies will extend our exciting recent discoveries of candidate drugs that inhibit the growth of C. neoformans in culture. In summary, our project will provide advanced knowledge into the ways that fungal pathogens cause infections in humans, and support the discovery and application of new methods to treat fungal diseases.
Programme
Project Grant
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
488010
Name
Kronstad James W
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Mitophagy as a target for antifungal therapy
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$956,250
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Aids; Antifungal Drugs; Cell Biology; Cryptococcus Neoformans; Fungal Pathogenesis; Medical Mycology; Mitochondria; Mitophagy; Molecular Genetics; Proteomics
Abstract
Humans are continuously exposed to fungi that can potentially cause disease or allergic reactions. For example, the pathogenic fungus Cryptococcus neoformans causes life threatening meningitis in people with defective immune systems. The global impact of this fungal pathogen is dramatically illustrated by the fact that it is responsible ~15% of deaths in patients with Acquired Immune Deficiency Syndrome (AIDS). C. neoformans is therefore a major threat to the ~37 million people suffering from AIDS worldwide. Alarmingly, a related species, Cryptococcus gattii, has emerged as a primary pathogen with the ability to cause meningitis in people with healthy immune systems. The disease caused by C. gattii is particularly relevant to the health of Canadians because the fungus has caused an outbreak in British Columbia. The long-term goal of our research project is to acquire knowledge that will lead to new strategies to prevent and/or effectively treat the infections caused by fungal pathogens. In particular, we are working to acquire a detailed understanding of the weapons that fungi deploy to attack people, and to use our new knowledge in strategies to treat fungal diseases. In our current project, we will determine how C. neoformans senses nutrients and stress conditions relevant to growth inside animal hosts. We plan to use the latest technologies in genetics, biochemistry and cell biology to complete our objectives. The new knowledge we obtain may lead to therapies that enhance the ability of our immune systems to control disease by preventing the fungus from growing during infection. These studies will extend our exciting recent discoveries of candidate drugs that inhibit the growth of C. neoformans in culture. In summary, our project will provide advanced knowledge into the ways that fungal pathogens cause infections in humans, and support the discovery and application of new methods to treat fungal diseases.
Competitiondate
202309
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Kronstad, James W
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $956,250~ $0~